NO844443L - Sett eller utstyr og fremgangsmaate for administrering av gangliosider og derivater derav ved inhalering - Google Patents

Sett eller utstyr og fremgangsmaate for administrering av gangliosider og derivater derav ved inhalering

Info

Publication number
NO844443L
NO844443L NO844443A NO844443A NO844443L NO 844443 L NO844443 L NO 844443L NO 844443 A NO844443 A NO 844443A NO 844443 A NO844443 A NO 844443A NO 844443 L NO844443 L NO 844443L
Authority
NO
Norway
Prior art keywords
gangliosides
inhalation
administration
derivatives
procedure
Prior art date
Application number
NO844443A
Other languages
English (en)
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of NO844443L publication Critical patent/NO844443L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Otolaryngology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO844443A 1983-11-08 1984-11-07 Sett eller utstyr og fremgangsmaate for administrering av gangliosider og derivater derav ved inhalering NO844443L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative

Publications (1)

Publication Number Publication Date
NO844443L true NO844443L (no) 1985-05-09

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO844443A NO844443L (no) 1983-11-08 1984-11-07 Sett eller utstyr og fremgangsmaate for administrering av gangliosider og derivater derav ved inhalering

Country Status (22)

Country Link
US (1) US4639437A (no)
EP (1) EP0145209B1 (no)
JP (1) JPS60132920A (no)
KR (1) KR850003503A (no)
AT (1) ATE47035T1 (no)
AU (1) AU569920B2 (no)
BE (1) BE900994A (no)
CH (1) CH662278A5 (no)
DE (1) DE3480053D1 (no)
DK (1) DK160129C (no)
ES (1) ES8608532A1 (no)
FR (1) FR2554346B1 (no)
GR (1) GR80853B (no)
IL (1) IL73292A (no)
IN (1) IN163563B (no)
IT (1) IT1212896B (no)
LU (1) LU85633A1 (no)
MX (1) MX163574B (no)
NO (1) NO844443L (no)
NZ (1) NZ209974A (no)
PT (1) PT79466B (no)
ZA (1) ZA848541B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
AU6909091A (en) * 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
EP1603932B1 (en) 2003-03-06 2012-10-03 Seneb Biosciences Inc. Methods and compositions for the enzymatic synthesis of gangliosides
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (no) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
KR850003503A (ko) 1985-06-20
ES537300A0 (es) 1986-07-16
MX163574B (es) 1992-06-02
CH662278A5 (fr) 1987-09-30
BE900994A (nl) 1985-05-07
EP0145209A2 (en) 1985-06-19
ES8608532A1 (es) 1986-07-16
US4639437A (en) 1987-01-27
FR2554346B1 (fr) 1987-11-20
PT79466A (en) 1984-12-01
FR2554346A1 (fr) 1985-05-10
EP0145209A3 (en) 1986-11-26
IL73292A (en) 1988-07-31
DK505584A (da) 1985-05-09
IN163563B (no) 1988-10-08
DK160129B (da) 1991-02-04
DK505584D0 (da) 1984-10-23
PT79466B (en) 1986-12-12
AU3518984A (en) 1985-05-16
IL73292A0 (en) 1985-01-31
JPS60132920A (ja) 1985-07-16
ATE47035T1 (de) 1989-10-15
GR80853B (en) 1985-02-26
EP0145209B1 (en) 1989-10-11
IT8349288A0 (it) 1983-11-08
DE3480053D1 (en) 1989-11-16
IT1212896B (it) 1989-11-30
JPH0211570B2 (no) 1990-03-14
ZA848541B (en) 1985-06-26
NZ209974A (en) 1987-02-20
DK160129C (da) 1991-07-01
LU85633A1 (fr) 1985-06-04
AU569920B2 (en) 1988-02-25

Similar Documents

Publication Publication Date Title
NO844443L (no) Sett eller utstyr og fremgangsmaate for administrering av gangliosider og derivater derav ved inhalering
PT93947A (pt) Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
EP0467164A3 (en) Use of the compound flupirtine against muscle bracing
FI881877A (fi) 17 -(cyklopropylamino) androst-5 -en-3 -ol och naerstaoende foereningar, som aer anvaendbara som c17-20-lyas-inhibitorer.
DE3474662D1 (en) Benzothiophene derivates as bronchodilators
IL83775A0 (en) Fumaramide derivatives and pharmaceutical compositions containing them for treating skin diseases
DE3268024D1 (en) 0-alkyl-0-carbamoyl-glycero-phospho-cholines and process for their preparation
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
IT7849227A0 (it) Procedimento per la separazione di pirrolidone-2 da polipirrolidone
ZA814902B (en) Novel thiazol-2-yl-oxamic acid derivatives,their preparation and therapeutic agents containing these compounds
ES2053590T3 (es) 3-fenil-7h-tiazolo(3,2-b)(1,2,4)triazin-7-onas sustituidas, procedimiento para su preparacion, medicamentos que las contienen y su empleo, asi como algunos productos intermedios formados durante la preparacion de los compuestos mencionados.
SU657813A1 (ru) Аппарат дл лечени переломов костей
SE8201308D0 (sv) Alkylendiaminderivat och forfarande for framstellning derav
ZA767652B (en) Process for the treatment of patients suffering from disorders induced by sludging
DE3160018D1 (en) Use of s-benzyl-3-benzylthiopropionthioate in pharmaceutical compositions
ES528323A0 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona
IT7830959A0 (it) Metodo per la cura della psoriasi.
ES487589A0 (es) Procedimiento de preparacion de ditiocarbamatos.(como divisional de la patente numero 486050)